UBS O'Connor’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,770
Closed -$1.53M 443
2025
Q2
$1.53M Buy
+3,770
New +$1.58M 0.04% 176
2023
Q4
Sell
-2,950
Closed -$1.49M 602
2023
Q3
$1.49M Sell
2,950
-5,500
-65% -$2.93M 0.03% 287
2023
Q2
$4.41M Buy
+8,450
New +$4.56M 0.09% 138
2016
Q1
Sell
-18,000
Closed -$2.55M 532
2015
Q4
$2.55M Buy
+18,000
New +$2.4M 0.02% 296
2015
Q3
Sell
-7,066
Closed -$916K 750
2015
Q2
$916K Buy
7,066
+3,960
+127% +$516K 0.01% 606
2015
Q1
$418K Buy
+3,106
New +$400K ﹤0.01% 691
2013
Q3
Sell
-72,000
Closed -$6.09M 557
2013
Q2
$6.09M Buy
+72,000
New +$5.99M 0.11% 216

Other funds holding TMO

UBS O'Connor's TMO Position: Q3 2025 in Review

UBS O'Connor sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 3,770 shares — an estimated $1.53M sold.

UBS O'Connor first reported a position in TMO in Q2 2013 and held it in 7 quarters. The position peaked at $6.09M in Q2 2013. 2,515 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • UBS O'Connor reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 3,770 Thermo Fisher Scientific shares in Q3 2025, an estimated $1.53M.
  • UBS O'Connor first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 7 quarters.
  • UBS O'Connor's Thermo Fisher Scientific position peaked at $6.09M in Q2 2013.
  • 2,515 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.